BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23698293)

  • 1. Footprint of APOBEC3 on the genome of human retroelements.
    Anwar F; Davenport MP; Ebrahimi D
    J Virol; 2013 Jul; 87(14):8195-204. PubMed ID: 23698293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition.
    Schumann GG
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):637-42. PubMed ID: 17511669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements.
    Esnault C; Priet S; Ribet D; Heidmann O; Heidmann T
    Retrovirology; 2008 Aug; 5():75. PubMed ID: 18702815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
    Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
    PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.
    Bogerd HP; Wiegand HL; Hulme AE; Garcia-Perez JL; O'Shea KS; Moran JV; Cullen BR
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8780-5. PubMed ID: 16728505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
    Refsland EW; Hultquist JF; Harris RS
    PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations.
    Duggal NK; Fu W; Akey JM; Emerman M
    Virology; 2013 Sep; 443(2):329-37. PubMed ID: 23755966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.
    Schumacher AJ; Nissley DV; Harris RS
    Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9854-9. PubMed ID: 16000409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of Alu retrotransposition by APOBEC3G.
    Hulme AE; Bogerd HP; Cullen BR; Moran JV
    Gene; 2007 Apr; 390(1-2):199-205. PubMed ID: 17079095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3 proteins inhibit human LINE-1 retrotransposition.
    Muckenfuss H; Hamdorf M; Held U; Perković M; Löwer J; Cichutek K; Flory E; Schumann GG; Münk C
    J Biol Chem; 2006 Aug; 281(31):22161-22172. PubMed ID: 16735504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
    Esnault C; Heidmann O; Delebecque F; Dewannieux M; Ribet D; Hance AJ; Heidmann T; Schwartz O
    Nature; 2005 Jan; 433(7024):430-3. PubMed ID: 15674295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.
    Stenglein MD; Harris RS
    J Biol Chem; 2006 Jun; 281(25):16837-16841. PubMed ID: 16648136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroelements versus APOBEC3 family members: No great escape from the magnificent seven.
    Arias JF; Koyama T; Kinomoto M; Tokunaga K
    Front Microbiol; 2012; 3():275. PubMed ID: 22912627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.
    Tan L; Sarkis PT; Wang T; Tian C; Yu XF
    FASEB J; 2009 Jan; 23(1):279-87. PubMed ID: 18827027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction.
    Koito A; Ikeda T
    Wiley Interdiscip Rev RNA; 2012; 3(4):529-41. PubMed ID: 22549984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of APOBEC3G binding to 7SL RNA.
    Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
    Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome.
    Ebrahimi D; Anwar F; Davenport MP
    Retrovirology; 2012 Dec; 9():113. PubMed ID: 23256516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of the Complicated Scenario of Primate APOBEC3 Gene Evolution.
    Uriu K; Kosugi Y; Suzuki N; Ito J; Sato K
    J Virol; 2021 May; 95(12):. PubMed ID: 33789992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV restriction by APOBEC3 in humanized mice.
    Krisko JF; Martinez-Torres F; Foster JL; Garcia JV
    PLoS Pathog; 2013 Mar; 9(3):e1003242. PubMed ID: 23555255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
    Koito A; Ikeda T
    Front Microbiol; 2013; 4():28. PubMed ID: 23431045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.